NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...

Go to the doctor to provide a blood sample, and you're typically faced with a needle and syringe, and hours or even days of ...

Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in ...

Adolescents 10 to 19 years old had a 55% higher risk for a new diagnosis of type 2 diabetes 1 month after a COVID diagnosis ...

Results from a new study suggest a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could ...

Here’s a golden chance for patients with diabetes or anyone who may be interested in keeping a check on their blood sugar ...

These DIY kits are a $5 billion industry. We report on the pros, the cons, and the ones to avoid at all costs.

Who needs to worry about colon cancer, and what tests will we be able to use in the future for early cancer detection?

Quanterix (NASDAQ:QTRX) Corporation (NASDAQ: QTRX), known for its ultra-sensitive biomarker detection, announced today the commercial availability of its Simoa p-Tau 217 Planar Kit. The kit ... the ...

instrumentation and consumables to develop p-Tau 217 blood tests and services using p-Tau 217 antibody technology licensed from Lilly. The Simoa® p-Tau 217 Planar Kit will be available immediately.

Depending on the type of test you receive, the test kit will include multiple parts and often requires swabbing one or both nostrils. The CDC urges anyone using an at-home test to thoroughly read ...